Email Us
View Reports

China Pharma Holdings, Inc. Company Profile

China Pharma Holdings, Inc. Company Profile - Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

  • ID : 3632714  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 39   |  
  • Publisher : Market Data Forecast

Company Overview:

China Pharma Holdings, through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd, is engaged in developing, manufacturing and marketing generic and brand pharmaceutical products for both western and traditional Chinese medicines in China. China Pharma Holdings focuses on therapeutics areas such as central nervous system (CNS) and cerebral-cardiovascular diseases; anti-infection and respiratory diseases; digestive diseases; and others. The company operates in China. It has 16 sales offices and over 1,000 sales representatives in China.

The company has a product portfolio of around 20 pharmaceutical products that address a variety of diseases and medical indications. China Pharma Holdings therapeutic products in the area of CNS and cerebral-cardiovascular diseases include cerebroprotein hydroloysate injection, gastrodin injection, propylgallate for injection, ozagrel sodium for injection, alginic sodium diester injection, bumetanide for injection, and candesartan.

The company's therapeutic products in the area of anti-infection and respiratory diseases comprises of roxithromycin dispersible tablets, cefaclor dispersible tablets, anhydroandrographolide, clarithromycin granules and capsules, naproxen sodium and pseudophedrine hydrochlorida sustained release tablets and gull wood extract syrup.

China Pharma Holdings' therapeutic products for digestive diseases include hepatocyte growth-promoting factor for injection, tiopronin, compound ammonium glycyrrhetate S for injection and omeparzole.

The company's other therapeutic products include vitamin B6 for injection, a vitamin supplement; and granisetron hydrochloride injection which is used to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors.

Scope of the Report

  • About the Company - Historical Details, Current Ownership Structure and basic overview of China Pharma Holdings, Inc. in terms of revenue, net income, and operating income.
  • Financials - Details about China Pharma Holdings, Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
  • Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
  • Company SWOT Analysis - Outlines China Pharma Holdings, Inc.’s strengths, weaknesses, and opportunities and threats facing the company.
  • Recent Developments - Showcases China Pharma Holdings, Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
  • Strategic Evaluation - Provides an overview of China Pharma Holdings, Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
  • Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

  • What domain does China Pharma Holdings, Inc. operate and what are key points about it?
  • What is the product / service portfolio of China Pharma Holdings, Inc.?
  • How has China Pharma Holdings, Inc. performed financially from the 2013?
  • How does China Pharma Holdings, Inc. rank among its peers in terms of revenue and market share?
  • What are China Pharma Holdings, Inc. strengths and weaknesses and what opportunities and threats does it face?
  • What are China Pharma Holdings, Inc.’s main growth strategies and how successful has the company been at implementing them?
  • What is the in-house technical capability of China Pharma Holdings, Inc.? Where does it procure / outsource it?

Reasons to buy

  • Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
  • Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
  • 12 hour delivery time fulfilling your urgent requests as per your requirement
  • On-demand customization options that can completely cater to your needs by focusing the report onto given specifics

1. About the Company

1.1 History and Basic Facts

1.2 Ownership Structure and Key Executives

1.3 Head Office

1.4 Other Locations & Subsidiaries

1.5 List of Competitors

1.6 Employee Count & Distribution

2. Financials

2.1 Company Type (Listed / Unlisted)

2.2 Annual Statements

2.3 Key Financial Highlights

2.4 Region-wise Breakdown

3. Product / Services

3.1 Overview

3.2 Description

4. SWOT Analysis

4.1 SWOT Overview

4.2 Strengths

4.3 Weaknesses

4.4 Opportunities

4.5 Threats

5. Recent Developments

5.1 Mergers & Acquisitions

5.2 Partnerships, Collaborations & Joint Ventures

5.3 New Product Launches

5.4 Business Expansion / Divestment

6. Strategic Evaluation

6.1 Corporate Strategy

6.2 Legal Issues

6.3 Analyst Outlook

7. Technology Landscape

7.1 Industry

7.1.1 Industry Snapshot

7.1.2 IT Spend

7.1.3 Key Information Technology Trends

7.2 Company

7.2.1 IT Overview

7.2.2 Key IT Technologies

7.2.3 Recent IT Initiatives

7.2.4 IT Outsourcing Engagements

7.2.5 Key IT Management

7.2.6 CIO/CTO Profile

Appendix

  • Methodology
  • About Us
  • Contact Us
  • Disclaimer

Fig.1: Company Snapshot

Fig.2: Locations Listing on Map

Table.1: Ownership Structure

Table.2: List of Competitors

Table.3: Annual Statements

Table.4: Key Financial Highlights

Table.5: Region-wise Breakdown

Table.6: Product/Services Overview

Table.7: Mergers & Acquisitions

Table.8: Partnerships, Collaborations & Joint Ventures

Table.9: New Product Launches

Table.10: Business Expansion / Divestment

Table 11: IT Budgets

Table 12: Key IT Management (CIO / CTO)

Table 13: IT Deals undertaken in the past years

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?